{"id":"W2803721928","doi":"10.1111/dom.13351","title":"Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim Japan; Eli Lilly and Company","keywords":"Empagliflozin; Placebo; Medicine; Pharmacodynamics; Insulin; Internal medicine; Randomized controlled trial; Diabetes mellitus; Pharmacokinetics; Type 2 diabetes; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003849782,0.001809557,0.003821641,0.0003164849,0.0005115165,0.0008716023,0.0007794567,0.001891223,0.00335455],"category_scores_gemma":[0.002104919,0.0008382174,0.002150751,0.0004497958,0.0008413001,0.001085546,0.0004343557,0.002112868,0.000452473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005992419,"about_ca_system_score_gemma":0.001475439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009277853,"about_ca_topic_score_gemma":0.00236627,"domain_scores_codex":[0.9988559,0.000621806,0.00009973061,0.0002233991,0.00009182219,0.0001072715],"domain_scores_gemma":[0.9990126,0.0001885042,0.0002639759,0.00008824766,0.0001274359,0.0003191786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9714264,0.008784203,0.001048258,0.0009736912,0.001530897,0.00003048451,0.00006882232,0.0001104408,0.003215549,0.00002281339,0.0003859754,0.01240249],"study_design_scores_gemma":[0.932723,0.06086742,0.004316492,0.00003509539,0.00128725,0.000018384,0.00001547089,0.0001634967,0.0002562273,0.00002212856,0.0002831775,0.0000118833],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868666,0.005346042,0.0007492788,0.0005020729,0.000361643,0.004454547,0.0005910491,0.00007058616,0.001058198],"genre_scores_gemma":[0.9804575,0.004395242,0.002903234,0.001135362,0.000630776,0.007917196,0.0009128915,0.00001876108,0.001629012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003849782,"threshold_uncertainty_score":0.02035981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03184946405653108,"score_gpt":0.3047898708028425,"score_spread":0.2729404067463114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}